Get the Stockscreener App
21.29
0.09%
0.02
Elanco Animal Health Inc stock is traded at $21.29, with a volume of 5.38M.
It is up +0.09% in the last 24 hours and down -3.45% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$21.27
Open:
$21.3
24h Volume:
5.38M
Relative Volume:
1.00
Market Cap:
$10.58B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
53.22
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
-2.79%
1M Performance:
-3.45%
6M Performance:
+50.25%
1Y Performance:
+69.10%
1-Day Range:
$20.96
$21.50
1-Week Range:
$20.41
$22.19
52-Week Range:
$8.02
$23.70
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
21.29 | 10.57B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-19-25 | Upgrade | Argus | Hold → Buy |
| Oct-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-17-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-26-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-09-24 | Initiated | UBS | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Market Perform |
| Sep-19-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
All You Need to Know About Elanco Animal Health (ELAN) Rating Upgrade to Buy - Yahoo Finance
Analysts’ Top Healthcare Picks: Elanco Animal Health (ELAN), Mediwound (MDWD) - The Globe and Mail
Stifel Nicolaus Sticks to Their Buy Rating for Elanco Animal Health (ELAN) - The Globe and Mail
Animal Health Focused Elanco Details Pipeline Momentum, US Investments, Cost-Saving Plans - Benzinga
Elanco Animal Health Shifts Focus to U.S., Redefining Livestock R&D and Manufacturing - Bovine Veterinarian
Elanco Animal Health: Strategic Dual Channel Focus and Robust Innovation Pipeline Drive Buy Rating - TipRanks
Elanco Animal Health stock price target raised to $26 at Leerink Partners - Investing.com Canada
Elanco restructuring to affect 600 positions across the company - Feed Strategy
Stifel reiterates Buy rating on Elanco Animal Health stock, maintains $27 price target - Investing.com Canada
Elanco Animal Health (NYSE:ELAN) Rating Increased to Strong-Buy at Barclays - MarketBeat
Elanco Invests $400 Million in Indiana to Expand U.S. R&D and Manufacturing Operations - Southeast AgNET
How Protein And Pets Drove Elanco Animal Health's Double-Digit Gain In 2025 - Investor's Business Daily
Elanco (ELAN) Announces Major Cost-Cutting Initiative - GuruFocus
Barclays Initiates Coverage on Elanco Animal Health (ELAN) with Overweight Rating | ELAN Stock News - GuruFocus
Elanco Animal Health Incorporated Announces Organizational Changes - marketscreener.com
Elanco Animal Health (NYSE:ELAN) Coverage Initiated by Analysts at Barclays - MarketBeat
Elanco Animal Health Incorporated Announces Continued Investment in Its U.S. Operations, Workforce and Communities over the Next Five Years - marketscreener.com
Elanco (ELAN) Outlines Promising Financial Projections for 2026 Onward - GuruFocus
Elanco Investor Day Defines New Era as Sustainable Growth Company - PR Newswire
Norges Bank Purchases New Shares in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Acquired by Hsbc Holdings PLC - MarketBeat
What downside risks could hit Elanco Animal Health Incorporated stockJuly 2025 PostEarnings & Fast Entry Momentum Trade Alerts - Newser
Will Elanco Animal Health Incorporated (5EA) stock outperform benchmarksOptions Play & Long-Term Investment Growth Plans - Newser
Why retail traders accumulate Elanco Animal Health Incorporated stockQuarterly Trade Summary & Weekly Watchlist for Consistent Profits - Newser
Why institutional investors increase stakes in Elanco Animal Health Incorporated stockWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - Newser
ELAN SEC FilingsElanco Animal Health 10-K, 10-Q, 8-K Forms - Stock Titan
Channing Capital Management LLC Decreases Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Aquatic Veterinary Market Set to See Booming Growth 2025-2032 - openPR.com
Is Elanco Animal Health Incorporated stock vulnerable to rate hikesTrade Analysis Summary & Capital Efficiency Focused Strategies - Newser
SG Americas Securities LLC Sells 70,517 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Will Elanco Animal Health Incorporated stock beat international competitionMarket Trend Review & Expert-Curated Trade Recommendations - Newser
Elanco Animal Health (NYSE: ELAN) reports 10,314-share equity grant to director - Stock Titan
Elanco (ELAN) director reports 10,314-share deferred stock unit award - Stock Titan
Elanco (NYSE: ELAN) director R. David Hoover reports 10,314-share board equity award - Stock Titan
Elanco (ELAN) board director receives 10,314 deferred stock units in annual grant - Stock Titan
Elanco Animal Health (ELAN) director reports 10,314-share deferred stock grant - Stock Titan
Elanco (ELAN) director awarded 10,314 deferred stock units in Form 4 filing - Stock Titan
Can Elanco Animal Health Incorporated (5EA) stock retain market dominance - Newser
Legal & General Group Plc Boosts Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Position Raised by Brandes Investment Partners LP - MarketBeat
Can Elanco Animal Health Incorporated (5EA) stock deliver consistent EPS growthJuly 2025 Action & Momentum Based Trading Ideas - Newser
Will Elanco Animal Health Incorporated (5EA) stock boost dividends furtherTake Profit & Low Drawdown Investment Ideas - Newser
Is Elanco Animal Health Incorporated stock vulnerable to regulatory risksLong Setup & Weekly Watchlist of Top Performers - Newser
mRNA Vaccines for Animals Market Forecast 2025-2032: Emerging - openPR.com
Creative Planning Increases Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (NYSE:ELAN) Stock Steady on Sector Review - Kalkine Media
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Ensign Peak Advisors Inc Cuts Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (ELAN) Is Up 8.6% After FDA Clears First Cat Screwworm Treatment – Has the Bull Case Changed? - Yahoo Finance
Can Elanco Animal Health Incorporated stock beat market expectations this quarterJuly 2025 Update & Free Low Drawdown Momentum Trade Ideas - BỘ NỘI VỤ
Aug Decliners: Is Elanco Animal Health Incorporated stock dividend yield sustainableIPO Watch & High Return Trade Guides - BỘ NỘI VỤ
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.50%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):